Konovo, a technology-first healthcare intelligence company, formally launched today with a new mission to simplify and enable research across the insights ecosystem of researchers, vendors and data ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be presented at the ...

Shares of Revvity Inc. RVTY slipped 1.30% to $93.43 Wednesday, on what proved to be an all-around favorable trading session ...

Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. Revvity met analysts’ revenue expectations last quarter ...

Shares of Revvity Inc. RVTY rose 1.55% to $95.13 Thursday, on what proved to be an all-around great trading session for the ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Revvity, Inc. (RVTY) on Monday reported first-quarter earnings of $42.2 million. On a per-share basis, the Waltham, Massachusetts-based company said ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Revvity (RVTY – Research Report) yesterday and set a price target of $135.00.

It is worth considering Revvity (RVTY), which belongs to the Zacks Medical Services industry. When looking at the last two reports, this maker of scientific instruments has recorded a strong ...